Cargando…

Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions

Pancreatic adenocarcinoma displays a variety of molecular changes that evolve exponentially with time and lead cancer cells not only to survive, but also to invade the surrounding tissues and metastasise to distant sites. These changes include: genetic alterations in oncogenes and cancer suppressor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gnoni, Antonio, Licchetta, Antonella, Scarpa, Aldo, Azzariti, Amalia, Brunetti, Anna Elisabetta, Simone, Gianni, Nardulli, Patrizia, Santini, Daniele, Aieta, Michele, Delcuratolo, Sabina, Silvestris, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821583/ https://www.ncbi.nlm.nih.gov/pubmed/24084722 http://dx.doi.org/10.3390/ijms141019731

Ejemplares similares

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
por: Gnoni, Antonio, et al.
Publicado: (2019)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review
por: Longo, Vito, et al.
Publicado: (2019)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
por: Azzariti, Amalia, et al.
Publicado: (2016)

Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option
por: Argentiero, Antonella, et al.
Publicado: (2020)

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
por: Longo, Vito, et al.
Publicado: (2016)

Immune system and bone microenvironment: rationale for targeted cancer therapies
por: Gnoni, Antonio, et al.
Publicado: (2020)

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
por: Argentiero, Antonella, et al.
Publicado: (2019)

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
por: Simone, Valeria, et al.
Publicado: (2017)

miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives
por: Gisel, Andreas, et al.
Publicado: (2014)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
por: Rossi, Elisabetta, et al.
Publicado: (2021)

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
por: Fasano, Rossella, et al.
Publicado: (2021)

Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis
por: Doronzo, Antonio, et al.
Publicado: (2023)

Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions
por: Zagouri, Flora, et al.
Publicado: (2010)

Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016)

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
por: Argentiero, Antonella, et al.
Publicado: (2019)

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
por: Porcelli, Letizia, et al.
Publicado: (2019)

Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions
por: Dombek, Gabrielle E., et al.
Publicado: (2022)

Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway
por: Pan, Yi, et al.
Publicado: (2018)

Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
por: Riva, Giulio, et al.
Publicado: (2018)

Pterostilbene and Probiotic Complex in Chemoprevention of Putative Precursor Lesions for Colorectal Cancer in an Experimental Model of Intestinal Carcinogenesis with 1,2-Dimethylhydrazine
por: Barreira, Márcio Alencar, et al.
Publicado: (2023)

The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue
por: Bundgaard-Nielsen, Caspar, et al.
Publicado: (2019)

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
por: Guida, Michele, et al.
Publicado: (2018)

PSCA and Oct-4 Expression in the Benign and Malignant Lesions of Gallbladder: Implication for Carcinogenesis, Progression, and Prognosis of Gallbladder Adenocarcinoma
por: Zou, Qiong, et al.
Publicado: (2013)

Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
por: Mauri, Giorgio, et al.
Publicado: (2015)

CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
por: Scarpa, Marco, et al.
Publicado: (2016)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
por: Carbone, Carmine, et al.
Publicado: (2014)

Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma
por: Zhu, Jianhui, et al.
Publicado: (2017)

Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey
por: Santini, Daniele, et al.
Publicado: (2014)

Development of an in vitro carcinogenesis model of human papillomavirus‐induced cervical adenocarcinoma
por: Zhang, Mengzhu, et al.
Publicado: (2021)

Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis
por: Soong, T. Rinda, et al.
Publicado: (2018)

Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
por: Gkountakos, Anastasios, et al.
Publicado: (2023)

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey
por: Silvestris, Nicola, et al.
Publicado: (2013)

Sirtuins and SIRT6 in Carcinogenesis and in Diet
por: de Céu Teixeira, Maria, et al.
Publicado: (2019)

The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line
por: Pagliarulo, Vincenzo, et al.
Publicado: (2013)

miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review
por: Alemar, Bárbara, et al.
Publicado: (2015)

Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience
por: Lachter, Jesse, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l0m11e2lte6n7pa0aknn5d80sk